Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Rokkas

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Annals of Gastroenterology|January 6, 2022
Assessment of first-line eradication treatment in Greece: data from the European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg)Theodore Rokkas, Sotirios Georgopoulos, Spyros Michopoulos, et al.
BMC Medicine|December 22, 2024
Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysisAryan Salahi-Niri, Ali Nabavi-Rad, Tanya Marie Monaghan, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic ReviewCassandra Mah, Thisun Jayawardana, Gary Leong, et al.
Helicobacter|November 7, 2019
Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysisApostolis Papaefthymiou, Christos Liatsos, Sotirios D Georgopoulos, et al.
Medicina (Kaunas, Lithuania)|March 22, 2020
Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against <i>Helicobacter pylori</i> Infection in Greece: Do National Health Policy-Makers Need to Care?Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, et al.
Gut|February 21, 2024
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updatesMassimo Rugge, Robert M Genta, Peter Malfertheiner, et al.
Gut|April 12, 2012
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus ReportPeter Malfertheiner, Francis Megraud, Colm A O'Morain, et al.
Gut|August 9, 2022
Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus reportPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Annals of Gastroenterology|January 6, 2022
Assessment of first-line eradication treatment in Greece: data from the European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg)Theodore Rokkas, Sotirios Georgopoulos, Spyros Michopoulos, et al.
BMC Medicine|December 22, 2024
Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysisAryan Salahi-Niri, Ali Nabavi-Rad, Tanya Marie Monaghan, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic ReviewCassandra Mah, Thisun Jayawardana, Gary Leong, et al.
Helicobacter|November 7, 2019
Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysisApostolis Papaefthymiou, Christos Liatsos, Sotirios D Georgopoulos, et al.
Medicina (Kaunas, Lithuania)|March 22, 2020
Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against <i>Helicobacter pylori</i> Infection in Greece: Do National Health Policy-Makers Need to Care?Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, et al.
Gut|February 21, 2024
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updatesMassimo Rugge, Robert M Genta, Peter Malfertheiner, et al.
Gut|April 12, 2012
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus ReportPeter Malfertheiner, Francis Megraud, Colm A O'Morain, et al.
Gut|August 9, 2022
Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus reportPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
Pageof 9